Frontotemporal EEG as potential biomarker for early MCI: a case–control study

Frontotemporal EEG as potential biomarker for early MCI: a case–control study

Background: Previous studies using EEG (electroencephalography) as biomarker for dementia have attempted to research, but results have been inconsistent. Most of the studies have extremely small number of samples (average N = 15) and studies with large number of data do not have control group. We id...

Full description

Bibliographic Details
Main Authors: Ikaga, T. (Author), Mitsukura, Y. (Author), Nishimura, T. (Author), Sumali, B. (Author), Watanabe, H. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Alzheimer disease
Alzheimer Disease
biological marker
Biomarkers
case control study
Case-Control Studies
Clinical decision-making
cognitive defect
Cognitive Dysfunction
dementia
Dementia
EEG
electroencephalography
Electroencephalography
human
Humans
MCI
procedures
reproducibility
Reproducibility of Results
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items